01 1Nanjing King-friend Biochemical Pharmaceutical
01 1ENOXAPARIN SODIUM USP
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-12
Pay. Date : 2020-06-24
DMF Number : 34827
Submission : 2020-07-07
Status : Active
Type : II
20
Nanjing King Friend Biochemical Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ENOXAPARIN SODIUM USP, with a corresponding US DMF Number 34827.
Remarkably, this DMF maintains an Active status since its submission on July 07, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 12, 2020, and payment made on June 24, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
